90.28-1.9 (-2.02%)
22 Oct, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
Alembic Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
C
2012
Mar 31
2013
Mar 31
C
2014
Mar 31
R
2015
Mar 31
R
2016
Mar 31
C
2017
Mar 31
2018
Mar 31
R
2019
Mar 31
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
TTM
Jun 30
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
IR
Total Revenue
119.27180.26151.34145.46127.53140.29125.52123.8173.9373.5278.22127.24157.49221.89239.99238.99
Cost of Operating Revenue
93.08136.5686.7498.5490.91102.8284.6473.3535.3525.8126.8646.7554.2374.7683.6987.28
Gross Profit
26.1943.6964.6046.9136.6237.4640.8850.4638.5747.7151.3680.49103.25147.13156.30151.71
Gross Margin
22.024.242.732.328.726.732.640.852.264.965.763.365.666.365.163.5
Total Operating Expenses
131.65174.32131.66141.95127.55138.66118.19108.3773.8766.3969.1593.63108.46138.81161.56165.74
Operating Profit
-12.385.9419.683.50-0.021.637.3315.440.057.139.0733.6149.0283.0878.4373.25
Operating Margin
-10.43.313.02.4-1.25.812.50.19.711.626.431.137.432.730.7
Financing Income/(Expense) - Net
0.443.9512.5317.9024.8327.6931.1726.0188.965.3380.9558.8347.5763.7167.46-2.28
Profit before Taxes
-13.6211.0133.4623.4625.3326.6344.1844.6793.1717.0497.8686.80102.69155.50148.76146.31
Income Taxes
-1.42-0.483.94-0.690.61-0.862.393.590.133.2011.666.189.8210.9322.8322.48
Profit after Tax
-12.2011.4929.53106.60234.51145.39162.98213.10329.12342.84222.06190.65268.62310.68317.38320.63
PAT Margin
-10.26.419.573.3183.9103.6129.8172.1445.2466.4283.9149.8170.6140.0132.2134.2
EPS - Basic - ex Extraordinary Items
-467.750.431.113.998.785.446.108.2612.8213.358.657.4210.4612.1012.3612.48
EPS - Diluted - ex Extraordinary Items
-467.750.431.113.998.785.446.108.2612.8213.358.657.4210.4612.1012.3612.48
EBIT
-12.385.9419.683.50-0.021.637.3315.440.057.139.0733.6149.0283.0878.4373.25
EBITDA
-1.4515.8127.589.606.126.7210.8116.801.338.6410.8535.3456.8684.9280.5686.34
EBITDA Margin
-1.28.818.26.64.84.88.613.61.811.813.927.836.138.333.636.1

Balance Sheet

Abridged
Understanding Balance Sheet
Alembic Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2012
Mar 31
2013
Mar 31
C
2014
Mar 31
R
2015
Mar 31
R
2016
Mar 31
2017
Mar 31
2018
Mar 31
R
2019
Mar 31
2020
Mar 31
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
AR
AR
AR
AR
AR
AR
AR
AR
AR
AR
AR
AR
AR
AR
AR
Total Current Assets
17012915416116919118799163102143172137205197
Long-Term Investments
00009498164199197624777564551551475
Property Plant & Equipment - Net
195188180171146148132131134140134132132135171
Total Non-Current Assets
2212152024587068019721,1671,3082,3072,4892,0322,1912,2982,392
Total Assets
3913443566198759921,1591,2661,4712,4092,6322,2052,3292,5032,590
Total Current Liabilities
1631079153586859494659688490110101
Long Term Debt
-30----------7117
Total Non-Current Liabilities
3131353815131497536843535443
Total Liabilities
194138125917281735753112135127143164144
Total Shareholders' Equity
1972062315288039111,0861,2091,4182,2972,4972,0782,1862,3392,445
Total Equity
1972062315288039111,0861,2091,4182,2972,4972,0782,1862,3392,445
Total Liabilities & Equity
3913443566198759921,1591,2661,4712,4092,6322,2052,3292,5032,590

Cash Flow

Abridged
Understanding Cash Flow Statement
Alembic Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2012
Mar 31
C
2013
Mar 31
R
2014
Mar 31
2015
Mar 31
C
2016
Mar 31
2017
Mar 31
2018
Mar 31
2019
Mar 31
C
2020
Mar 31
R
2021
Mar 31
2022
Mar 31
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
12M
AR
Operating CF bef Changes in Working Cap
2.1517.5238.7129.5930.2131.5536.2043.3993.7617.3189.4784.92108.00149.49142.08
Working Capital - Increase/(Decrease)
-55.5861.67-36.5810.121.7046.0611.891.990.60-18.64-27.9011.44-38.47-0.6040.22
Net CF from Operating Activities
-53.4379.192.1339.7131.9177.6148.0945.3894.36-1.3361.5796.3669.52148.89182.30
Capital Expenditures - Net
4.132.580.590.15-1.2813.829.3922.9421.7347.2133.6324.7456.0150.7676.65
Net CF from Investing Activities
-11.32-2.581.41-13.91-27.14-72.84-47.0847.58-31.39-36.09-60.86-50.68-22.11-91.57-118.38
Dividends Paid - Cash - Total
-0.143.304.835.084.854.846.336.1215.285.1545.9256.2361.1761.41
Stock - Issuance/(Retirement) - Net
--------82.00-------
Debt - LT & ST - Issuance/(Retirement) - Total
64.86-78.34-0.55-19.290.000.052.34--0.28-0.28-9.155.30-3.81
Net Cash Flow from Financing Activities
64.86-78.48-3.85-24.12-5.07-4.80-2.49-88.32-6.12-15.00-5.43-45.92-47.09-55.87-65.22
Free Cash Flow to Equity
7.31-1.730.9920.2733.2063.8441.0422.4472.63-48.2627.6771.6222.66103.43101.84
Free Operating CF net dividend
-57.5975.86-1.7634.6826.4858.4418.7915.7165.89-64.0620.6124.62-43.0036.9544.23
Free Operating CF
-57.5976.001.5439.5131.5563.2923.6322.0472.01-48.7825.7670.5413.2398.12105.65

Business Segment Analysis

FY End:
Mar 26

Alembic Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales
Total₹ 232Cr
Real Estate Business (79.9%)₹ 185.35 CrActive Pharmaceutical Ingredients Business (20.1%)₹ 46.59 Cr
Assets
Total₹ 2,590Cr
Unallocated (73.1%)₹ 1,892.92 CrReal Estate Business (19.9%)₹ 515.78 CrActive Pharmaceutical Ingredients Business (7.0%)₹ 180.81 Cr

Regional Segment Analysis

Alembic Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Alembic Ltd.

Historical Segment Analysis

Track how Alembic Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
We don't have enough data to show the Capex for Alembic Ltd..

Frequently Asked Questions

What is the revenue of Alembic Ltd.?
The latest trailing twelve month revenue of Alembic Ltd. is ₹ 238.99 Cr, reflecting a 1-year growth of 8.21% and a 3-year CAGR of 18.95%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Alembic Ltd.?
The latest trailing twelve month net profit (PAT) of Alembic Ltd. is ₹ 320.63 Cr, with a 3-year earnings CAGR of 8.12%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Alembic Ltd.?
The trailing twelve month EBITDA of Alembic Ltd. is approximately ₹ 73.25 Cr (based on an operating margin of 30.65%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Alembic Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Alembic Ltd. is 12.48. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Alembic Ltd.?
The debt-to-equity ratio of Alembic Ltd. stands at 0.00. The interest coverage ratio is 32.15x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Alembic Ltd.?
The estimated book value per share of Alembic Ltd. is 95.22 (derived from a P/B ratio of 0.95 and market price of ₹ 90.28), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Alembic Ltd.?
The trailing twelve month operating cash flow of Alembic Ltd. is ₹ 182.30 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Alembic Ltd. report consolidated or standalone financials?
Alembic Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.